A Perspective on Nanoparticle Universal Influenza Vaccines

Area of Science:

• Immunology
• Vaccinology
• Nanotechnology

Background:

• Seasonal influenza vaccines require annual strain updates, which are difficult to predict accurately, leading to mismatched vaccines and reduced efficacy.
• Current vaccines are ineffective against unpredictable influenza pandemics, posing a significant global public health threat.
• A universal influenza vaccine is needed to overcome these limitations and prevent pandemics.

Purpose of the Study:

• To review the design of nanoparticle-based universal influenza vaccines.
• To highlight recent discoveries on nanoparticle features enhancing immunogenicity.
• To summarize progress in clinical trials for universal influenza vaccines.

Main Methods:

• Designing vaccine immunogens based on conserved, type-specific amino acid sequences and conformational epitopes.
• Utilizing nanotechnology, specifically layered protein nanoparticles, to improve vaccine immunogenicity and duration of immunity.
• Evaluating nanoparticle features that enhance immune responses and reviewing clinical trial data.

Main Results:

• Nanoparticle-based universal influenza vaccines can elicit broadly reactive humoral and cellular immunity.
• Layered protein nanoparticles improve vaccine immunogenicity by enhancing antigen recognition, processing, and immune response induction.
• Specific nanoparticle features have been identified that significantly boost immunogenicity and duration of protective immunity.

Conclusions:

• Universal influenza vaccines utilizing nanotechnology represent a promising strategy to overcome the limitations of current seasonal vaccines.
• Nanoparticle design is crucial for enhancing immunogenicity and achieving broad protection against influenza viruses.
• Ongoing clinical trials are evaluating the efficacy and safety of these advanced universal influenza vaccine candidates.